MINERVA BIOTECHNOLOGIES
Minerva Biotechnologies develops cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. Its stem cell technology could transform the field of regenerative medicine. It discovered that cancer cells are healthy cells that are being reprogrammed back to a stem cell state. It is also the first company to generate human naïve state pluripotent stem cells using a single, naturally occurring human stem cell growth factor. These earlier stem cells have a clean slate and are more easily directed to develop into functional mature cells, which could be used for transplant. It was founded in 1999 and is headquartered in Waltham, Massachusetts.
MINERVA BIOTECHNOLOGIES
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1999-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.minervabio.com
Total Employee:
11+
Status:
Active
Contact:
+1 781-487-0200
Email Addresses:
[email protected]
Total Funding:
65.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apache Mobile Non Scaleable Content Organization Schema Google Maps AJAX Libraries API
Similar Organizations
Candel Therapeutics
Candel Therapeutics develops cancer immunotherapies designed to improve the lives of cancer patients and their families.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.minervabio.com Semrush global rank: 9.73 M Semrush visits lastest month: 114
- Host name: 162-215-248-62.unifiedlayer.com
- IP address: 162.215.248.62
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
